AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 145 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $413,000 | +416.2% | 10,109 | +222.0% | 0.00% | – |
| Q1 2024 | $80,000 | -63.1% | 3,139 | -86.9% | 0.00% | – |
| Q4 2023 | $217,000 | +181.8% | 23,944 | +98.1% | 0.00% | – |
| Q3 2023 | $77,000 | -9.4% | 12,088 | +57.5% | 0.00% | – |
| Q2 2023 | $85,000 | +26.9% | 7,674 | +74.6% | 0.00% | – |
| Q1 2023 | $67,000 | -58.4% | 4,394 | -39.7% | 0.00% | – |
| Q4 2022 | $161,000 | +705.0% | 7,285 | +486.6% | 0.00% | – |
| Q3 2022 | $20,000 | +300.0% | 1,242 | +232.1% | 0.00% | – |
| Q2 2022 | $5,000 | -90.4% | 374 | -86.7% | 0.00% | – |
| Q1 2022 | $52,000 | -72.5% | 2,812 | -64.5% | 0.00% | – |
| Q4 2021 | $189,000 | -1.6% | 7,925 | +1.7% | 0.00% | – |
| Q3 2021 | $192,000 | +13.6% | 7,790 | +13.8% | 0.00% | – |
| Q2 2021 | $169,000 | +9.0% | 6,846 | -3.9% | 0.00% | – |
| Q1 2021 | $155,000 | +82.4% | 7,123 | +114.2% | 0.00% | – |
| Q4 2020 | $85,000 | – | 3,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |